<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04765410</url>
  </required_header>
  <id_info>
    <org_study_id>PDACmiRNA</org_study_id>
    <nct_id>NCT04765410</nct_id>
  </id_info>
  <brief_title>The Impact Of Tissue Micro-RNA Profile From EUS-FNA In Pancreatic Adenocarcinoma</brief_title>
  <acronym>EUS-FNA</acronym>
  <official_title>Tissue Micro-RNA Profile Collected Through Endoscopic Ultrasonography Fine-Needle-Aspiration (EUS-FNA) In Pancreatic Adenocarcinoma And Its Impact On Survival And Prognosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carol Davila University of Medicine and Pharmacy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bucharest Emergency Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institutul Clinic Fundeni</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Carol Davila University of Medicine and Pharmacy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreatic adenocarcinoma still represents one of the &quot;hot-topics&quot; worldwide. Endoscopic&#xD;
      ultrasonography was a breakthrough, bringing us closer to personalized treatment by getting&#xD;
      histopathological samples through fine-needle-aspiration or fine-needle-biopsy. These samples&#xD;
      can be analyzed and offer the possibility to detect a micro-RNA profile.&#xD;
&#xD;
      Micro-RNAs are small non-coding RNA molecules that interfere in genic expression. Many&#xD;
      studies focused on seric microRNA profile, though there are many implications in tissue&#xD;
      micro-RNA profile, thus overexpression or under expression of these molecules might help us&#xD;
      not only understand different cellular processes, but also interfere in personalized medicine&#xD;
      in the future.&#xD;
&#xD;
      The investigators propose a prospective, multicenter, randomized, cohort study on 60 patients&#xD;
      with solid pancreatic masses to evaluate tissue microRNA profile obtained by EUS-FNA.&#xD;
&#xD;
      The primary hypothesis is to correlate the microRNA tissular expression in pancreatic&#xD;
      adenocarcinoma with tumor aggressive behavior, survival and response to treatment.&#xD;
&#xD;
      The samples will be obtained from the participants during endoscopic ultrasonography, through&#xD;
      fine needle aspiration, after consent was given to be a part of the study prior to the&#xD;
      intervention. The probe will be preserved in a special recipient that stabilizes RNA and&#xD;
      inhibits RNA-lazes, thus preventing RNA degradation by endogenous ribonucleases.&#xD;
&#xD;
      The analysis of miRNA profile will be made using qRT-PCR array method, by miScript II RT Kit,&#xD;
      miScript SYBR Green PCR Kit È™i miScript miRNA PCR Array Human Cancer Pathway Finder&#xD;
      (MIHS-102Z) (Qiagen, GmbH). Thus a kit containing a number of 84 miRNAs will be analysed in&#xD;
      every participant.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 21, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change from baseline in Eastern Cooperative Oncology Group (ECOG) performance status, weight and survival in patients with pancreatic adenocarcinoma according to tissue microRNA expression</measure>
    <time_frame>through study completion, an average of 2 and a half years</time_frame>
    <description>Eastern Cooperative Oncology Group (ECOG) performance status, weight and survival will be assessed though different consultations (in person or by telemedicine): at first presentation, at 1 month, at 3 months, at 6 months and at one year.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pancreatic Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>Patients with solid pancreatic masses</arm_group_label>
    <description>Patients with solid pancreatic masses</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>EUS FNA (endoscopic ultrasound fine needle aspiration)</intervention_name>
    <description>Patients with solid pancreatic masses fulfilling the inclusion and exclusion criteria will receive EUS FNA (endoscopic ultrasound fine needle aspiration).</description>
    <arm_group_label>Patients with solid pancreatic masses</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The samples will be obtained from the participants during endoscopic ultrasonography, through&#xD;
      fine needle aspiration, after consent was given to be a part of the study prior to the&#xD;
      intervention. The probe will be preserved in a special recipient that stabilizes RNA and&#xD;
      inhibits RNA-lazes, thus preventing RNA degradation by endogenous ribonucleases.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with solid pancreatic masses fulfilling the inclusion and exclusion criteria will&#xD;
        receive EUS FNA (endoscopic ultrasound fine needle aspiration).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pancreatic solid mass, with or without a cystic component&#xD;
&#xD;
          -  Age over 18 years old&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cystic pancreatic mass with no solid component&#xD;
&#xD;
          -  Abnormal coagulation (elevated INR &gt;1.5, thrombocytopenia&lt;60 000/mm3, activated&#xD;
             partial thromboplastin time&gt;42 seconds), participant on anticoagulant treatment that&#xD;
             cannot stop the treatment&#xD;
&#xD;
          -  European Cooperative Oncology Group status 4&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Age under 18 years old&#xD;
&#xD;
          -  The participant does not want to sign the consent form, or is unable to&#xD;
&#xD;
          -  Difficult puncture position during endoscopic ultrasonography: vessels or Wirsung duct&#xD;
             positioned in front of the needle (decision of the endoscopist)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Catalina Vladut, MD</last_name>
    <phone>+40751015445</phone>
    <email>drcatalinavladut@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>&quot;Carol Davila&quot; University Central Emergency Hospital</name>
      <address>
        <city>Bucharest</city>
        <state>Sector 1</state>
        <zip>010825</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catalina Vladut, MD</last_name>
      <phone>+40751015445</phone>
      <email>drcatalinavladut@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Vasile Balaban, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>&quot;Prof Dr Agrippa Ionescu&quot; Emergency Hospital</name>
      <address>
        <city>Bucharest</city>
        <state>Sector 1</state>
        <zip>011356</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catalina Vladut, MD</last_name>
      <phone>+40751015445</phone>
      <email>drcatalinavladut@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mihai Ciocirlan, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Emergency Hospital Bucharest</name>
      <address>
        <city>Bucharest</city>
        <state>Sector 1</state>
        <zip>014461</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catalina Vladut, MD</last_name>
      <phone>+40751015445</phone>
      <email>drcatalinavladut@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Catalina Vladut, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Madalina Stan-Ilie, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundeni Clinical Institute</name>
      <address>
        <city>Bucharest</city>
        <state>Sector 2</state>
        <zip>022328</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>&quot;Victor Babes&quot; National Pathology Institute</name>
      <address>
        <city>Bucharest</city>
        <state>Sector</state>
        <zip>050096</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catalina Vladut, MD</last_name>
      <phone>+40751015445</phone>
      <email>drcatalinavladut@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Maria Dobre, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Milanesi, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 18, 2021</study_first_submitted>
  <study_first_submitted_qc>February 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>February 18, 2021</last_update_submitted>
  <last_update_submitted_qc>February 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Carol Davila University of Medicine and Pharmacy</investigator_affiliation>
    <investigator_full_name>Mihai Ciocirlan</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>microRNA</keyword>
  <keyword>endoscopic ultrasonography</keyword>
  <keyword>fine needle aspiration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

